Edition:
United States

Pfizer Acquires 15 Pct Ownership Stake In Vivet


Wednesday, 20 Mar 2019 06:45am EDT 

March 20 (Reuters) - Pfizer Inc ::PFIZER SECURES EXCLUSIVE OPTION TO ACQUIRE GENE THERAPY COMPANY VIVET THERAPEUTICS.PFIZER INC - PFIZER ACQUIRES 15% OWNERSHIP STAKE IN VIVET.PFIZER INC - PFIZER AND VIVET TO COLLABORATE ON DEVELOPMENT OF POTENTIAL BREAKTHROUGH THERAPY FOR WILSON DISEASE.PFIZER INC - PFIZER PAID APPROXIMATELY EUR 45 MILLION (US$51 MILLION) UPON SIGNING OF DEAL.PFIZER INC - MAY PAY UP TO EUR 560 MILLION (US$635.8 MILLION) INCLUSIVE OF OPTION EXERCISE PAYMENT.PFIZER INC - CAN EXERCISE OPTION TO ACQUIRE 100% OF VIVET FOLLOWING COMPANY'S DELIVERY OF CERTAIN DATA FROM PHASE I/II CLINICAL TRIAL FOR VTX-801.PFIZER INC - PFIZER SENIOR EXECUTIVE MONIKA VNUK, M.D., VICE PRESIDENT, WORLDWIDE BUSINESS DEVELOPMENT, WILL JOIN VIVET'S BOARD OF DIRECTORS.PFIZER INC - OTHER TERMS OF TRANSACTION WERE NOT DISCLOSED.PFIZER INC - SECURED AN EXCLUSIVE OPTION TO ACQUIRE ALL OUTSTANDING SHARES.